State of Wisconsin Investment Board
MDGL icon

State of Wisconsin Investment Board’s Madrigal Pharmaceuticals MDGL Stock Holding History

State of Wisconsin Investment Board’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.03M Buy
13,432
+4,156
+45% +$1.99M 0.02% 843
2025
Q4 		$5.4M Sell
9,276
-1,599
-15% -$817K 0.01% 975
2025
Q3 		$4.99M Buy
10,875
+1,881
+21% +$702K 0.01% 954
2025
Q2 		$2.72M Sell
8,994
-2,295
-20% -$684K 0.01% 1158
2025
Q1 		$3.74M Buy
11,289
+2,599
+30% +$854K 0.01% 1030
2024
Q4 		$2.68M Buy
8,690
+66
+0.8% +$18.6K 0.01% 1174
2024
Q3 		$1.83M Sell
8,624
-463
-5% -$118K ﹤0.01% 1344
2024
Q2 		$2.55M Buy
9,087
+510
+6% +$121K 0.01% 1196
2024
Q1 		$2.29M Sell
8,577
-280
-3% -$66K 0.01% 1208
2023
Q4 		$2.05M Sell
8,857
-2,276
-20% -$398K 0.01% 1233
2023
Q3 		$1.63M Sell
11,133
-2,798
-20% -$527K 0.01% 1299
2023
Q2 		$3.22M Buy
13,931
+2,295
+20% +$622K 0.01% 1155
2023
Q1 		$2.82M Buy
11,636
+144
+1% +$39.2K 0.01% 1203
2022
Q4 		$3.34M Sell
11,492
-739
-6% -$72.3K 0.01% 1146
2022
Q3 		$795K Buy
12,231
+697
+6% +$48.4K ﹤0.01% 1671
2022
Q2 		$826K Sell
11,534
-3,266
-22% -$240K ﹤0.01% 1771
2022
Q1 		$1.45M Hold
14,800
– – ﹤0.01% 1572
2021
Q4 		$1.25M Hold
14,800
– – ﹤0.01% 1380
2021
Q3 		$1.18M Buy
14,800
+3,100
+26% +$268K ﹤0.01% 1401
2021
Q2 		$1.14M Hold
11,700
– – ﹤0.01% 1415
2021
Q1 		$1.37M Sell
11,700
-800
-6% -$93.3K ﹤0.01% 1294
2020
Q4 		$1.39M Sell
12,500
-1,500
-11% -$183K ﹤0.01% 1261
2020
Q3 		$1.66M Sell
14,000
-900
-6% -$97.7K ﹤0.01% 1191
2020
Q2 		$1.69M Sell
14,900
-400
-3% -$39.3K ﹤0.01% 1153
2020
Q1 		$1.02M Sell
15,300
-13,261
-46% -$1.1M ﹤0.01% 1195
2019
Q4 		$2.6M Buy
28,561
+16,861
+144% +$1.64M 0.01% 1096
2019
Q3 		$1.01M Buy
11,700
+1,500
+15% +$141K ﹤0.01% 1140
2019
Q2 		$1.07M Buy
10,200
+200
+2% +$21.4K ﹤0.01% 1121
2019
Q1 		$1.25M Buy
10,000
+2,800
+39% +$348K ﹤0.01% 1100
2018
Q4 		$812K Buy
7,200
+100
+1% +$15.5K ﹤0.01% 1181
2018
Q3 		$1.52M Buy
7,100
+1,100
+18% +$276K ﹤0.01% 1091
2018
Q2 		$1.68M Buy
6,000
+3,000
+100% +$527K ﹤0.01% 1020
2018
Q1 		$350K Hold
3,000
– – ﹤0.01% 1348
2017
Q4 		$275K Buy
+3,000
New +$171K ﹤0.01% 1368

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wisconsin Investment Board's MDGL Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Madrigal Pharmaceuticals (MDGL) stake by 45% in Q1 2026, buying an estimated $1.99M and bringing the position to 13,432 shares worth $7.03M. The position accounts for 0.02% of the portfolio, ranked #843.

State of Wisconsin Investment Board first reported a position in MDGL in Q4 2017 and has held it in 34 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • State of Wisconsin Investment Board held 13,432 shares of Madrigal Pharmaceuticals worth $7.03M as of Q1 2026.
  • State of Wisconsin Investment Board bought 4,156 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $1.99M.
  • Madrigal Pharmaceuticals made up 0.02% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #843 holding.
  • State of Wisconsin Investment Board first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.